Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Scribd Logo
Upload

Welcome to Scribd!

  • 17 views

    Importance of Gene Therapy

    Uploaded by

    Kaye Purificacion
    Gene therapy gained commercial interest in the 1980s but hopes were dashed after the first patient death in 1999, it took a decade for optimism to return and from 2008 dozens of new startups in gene therapy were created backed by pharmaceutical funding and the stock market, showing how much potential was seen in gene therapy.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd

    Importance of Gene Therapy

    Uploaded by

    Kaye Purificacion
    17 views1 page
    Gene therapy gained commercial interest in the 1980s but hopes were dashed after the first patient death in 1999, it took a decade for optimism to return and from 2008 dozens of new startups in gene therapy were created backed by pharmaceutical funding and the stock market, showing how much potential was seen in gene therapy.

    Original Title

    IMPORTANCE OF GENE THERAPY

    Copyright

    © © All Rights Reserved

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Gene therapy gained commercial interest in the 1980s but hopes were dashed after the first patient death in 1999, it took a decade for optimism to return and from 2008 dozens of new startups in gene therapy were created backed by pharmaceutical funding and the stock market, showing how much potential was seen in gene therapy.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    17 views1 page

    Importance of Gene Therapy

    Uploaded by

    Kaye Purificacion
    Gene therapy gained commercial interest in the 1980s but hopes were dashed after the first patient death in 1999, it took a decade for optimism to return and from 2008 dozens of new startups in gene therapy were created backed by pharmaceutical funding and the stock market, showing how much potential was seen in gene therapy.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    of 1

    Gene therapy gained a lot of commercial interest in the 1980s.

    In part this was because many assumed


    such treatment would move swiftly and easily from proof of concept into clinical trials. Such hopes,
    however, were dashed following the death of the first patient in a gene therapy trial in 1999. It would
    take another decade before optimism about the therapy resurfaced. From 2008 onwards dozens of new
    start-ups began to be created around gene therapy. These were founded on the back of sponsorship
    from pharmaceutical companies and the stock market. Just how much weight began to be attached to
    gene therapy can be seen by the stock market’s valuation of Juno Therapeutics. In 2014, just one year
    after Juno was set up, the company was valued at US$4 billion. When the first gene therapy was
    approved in the United States there were 854 companies developing such therapies. According to the
    Alliance for Regenerative Medicine there were 1085 companies in that space by the end of 2020 and
    more than 400 gene therapy trials under way.

    You might also like